Daily compared with alternate-day levamisole in pediatric nephrotic syndrome: an open-label randomized controlled study
Pediatric Nephrology · 2024
DOI: 10.1007/s00467-024-06402-9 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Pediatric Nephrology, 2024. Verfasst von Sushmita Banerjee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Institute of Child Health, Kolkata, India. asban444@gmail.com. Hauptthemen laut MEDLINE: Levamisole, Nephrotic Syndrome, Recurrence. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Institute of Child Health, Kolkata, India. asban444@gmail.com.
- Department of Nephrology, Institute of Child Health, Kolkata, India.
- Department of Pharmacology, Institute of Post Graduate Medical Education & Research, Kolkata, India.
ORCID-Profile: Sushmita Banerjee
Zitieren
APA
Banerjee, S., Sengupta, J., Sinha, R., Chatterjee, S., Sarkar, S., Akhtar, S., Saha, R., & Pahari, A. (2024). Daily compared with alternate-day levamisole in pediatric nephrotic syndrome: an open-label randomized controlled study. Pediatric Nephrology. https://doi.org/10.1007/s00467-024-06402-9
Vancouver
Banerjee S, Sengupta J, Sinha R, Chatterjee S, Sarkar S, Akhtar S, et al. Daily compared with alternate-day levamisole in pediatric nephrotic syndrome: an open-label randomized controlled study. Pediatric Nephrology. 2024. doi:10.1007/s00467-024-06402-9
BibTeX
@article{Banerjee2024,
author = {Banerjee, Sushmita and Sengupta, Jayati and Sinha, Rajiv and Chatterjee, Suparna and Sarkar, Subhankar and Akhtar, Shakil and Saha, Rana and Pahari, Amitava},
title = {Daily compared with alternate-day levamisole in pediatric nephrotic syndrome: an open-label randomized controlled study},
journal = {Pediatric Nephrology},
year = {2024},
doi = {10.1007/s00467-024-06402-9}
}
EUVIMED